{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:05:23Z","timestamp":1784286323381,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Bonn"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-immune hydrops fetalis (NIHF) is a rare condition that can lead to serious cardiopulmonary compromise after birth, often resulting in the need for intensive cardiorespiratory support, and in selected cases including extracorporeal membrane oxygenation (ECMO). Outcome is complicated due to a high rate of preterm birth. Morbidity and mortality data regarding NIHF and outcome of ECMO treatment in this population are very sparse. This is the first update and analysis of the Extracorporeal Life Support Organization (ELSO) registry-based data of neonates with NIHF.\u00a0Neonatal patients with a diagnosis of NIHF and treated with ECMO during the years 2000\u20132024, reported to the ELSO registry, were retrospectively analyzed. Exclusion criteria were HF due to hemolytic disease, congenital diaphragmatic hernia (CDH), and major cardiac defects.\u00a0After the application of exclusion criteria, 171 patients remained for final analysis, of these 88 (52%) survived until discharge. Infants with a higher birth weight (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u2009.011) and those with a gestational age (GA)\u2009\u2265\u200935\u00a0weeks (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u2009.032), as well as female patients (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u2009.027), had significantly higher in-hospital survival rates. The ECMO support type (veno-arterial vs. veno-venous) did not influence in-hospital mortality rate (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u2009.524) or complication rate. Female sex and higher BW (&gt;\u20092.5\u00a0kg) remained independently associated with higher in-hospital survival after a binary logistic regression analysis.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    :\u00a0Mortality rates over the last 25\u00a0years remained largely unchanged. Our analysis revealed baseline characteristics as independent predictors for higher in-hospital survival in these patients. In comparison with other underlying conditions treated with neonatal ECMO, neonates with NIHF present comparable morbidity and mortality rates after veno-arterial or veno-venous ECMO treatment.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>NIHF is a rare neonatal disease leading to preterm birth and a high risk of cardiorespiratory compromise, sometimes resulting in the need for ECMO treatment<\/jats:italic>\n                              .\u2022\n                              <jats:italic>ECMO treatment for preterm infants is feasible, with increasing survival rates<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"2\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>After ECMO treatment, neonates with NIHF show acceptable complication rates and in-hospital survival, supporting a case-selective discussion of ECMO therapy<\/jats:italic>\n                              .\u2022\n                              <jats:italic>Both veno-arterial and veno-venous ECMO are potential rescue therapy options in experienced neonatal ECMO centers with comparable outcomes<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-07185-x","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T04:53:25Z","timestamp":1782449605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracorporeal membrane oxygenation in Non-Immune Hydrops fetalis \u2013 a registry-based data analysis over the last 25 years"],"prefix":"10.1007","volume":"185","author":[{"given":"Manuel","family":"Kuelshammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Sophie","family":"Matzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Moersdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Strizek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Dresbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemmen","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"7185_CR1","doi-asserted-by":"publisher","unstructured":"Bellini C et al (2015) Etiology of non-immune hydrops fetalis: an update. Am J Med Genet A 167A(5):1082\u20131088 https:\/\/doi.org\/10.1002\/ajmg.a.36988","DOI":"10.1002\/ajmg.a.36988"},{"issue":"5","key":"7185_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1002\/ajmg.a.32655","volume":"149A","author":"C Bellini","year":"2009","unstructured":"Bellini C et al (2009) Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Genet A 149A(5):844\u2013851. https:\/\/doi.org\/10.1002\/ajmg.a.32655","journal-title":"Am J Med Genet A"},{"issue":"5","key":"7185_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/cge.14309","volume":"103","author":"HB Al-Kouatly","year":"2023","unstructured":"Al-Kouatly HB et al (2023) Diagnostic yield from prenatal exome sequencing for non-immune hydrops fetalis: a systematic review and meta-analysis. Clin Genet 103(5):503\u2013512. https:\/\/doi.org\/10.1111\/cge.14309","journal-title":"Clin Genet"},{"issue":"11","key":"7185_CR4","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/pd.6022","volume":"41","author":"ARE Correa","year":"2021","unstructured":"Correa ARE et al (2021) Utility of fetal whole exome sequencing in the etiological evaluation and outcome of nonimmune hydrops fetalis. Prenat Diagn 41(11):1414\u20131424. https:\/\/doi.org\/10.1002\/pd.6022","journal-title":"Prenat Diagn"},{"issue":"5","key":"7185_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63494","volume":"194","author":"MM Makhamreh","year":"2024","unstructured":"Makhamreh MM et al (2024) RASopathies are the most common set of monogenic syndromes identified by exome sequencing for nonimmune hydrops fetalis: a systematic review and meta-analysis. Am J Med Genet A 194(5):e63494. https:\/\/doi.org\/10.1002\/ajmg.a.63494","journal-title":"Am J Med Genet A"},{"issue":"1","key":"7185_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1542\/peds.2006-3680","volume":"120","author":"ME Abrams","year":"2007","unstructured":"Abrams ME, Meredith KS, Kinnard P, Clark RH (2007) Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics 120(1):84\u201389. https:\/\/doi.org\/10.1542\/peds.2006-3680","journal-title":"Pediatrics"},{"issue":"3","key":"7185_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/uog.22019","volume":"56","author":"FG Sileo","year":"2020","unstructured":"Sileo FG et al (2020) Non-immune fetal hydrops: etiology and outcome according to gestational age at diagnosis. Ultrasound Obstet Gynecol 56(3):416\u2013421. https:\/\/doi.org\/10.1002\/uog.22019","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9","key":"7185_CR8","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1055\/a-2008-2495","volume":"40","author":"K Swanson","year":"2023","unstructured":"Swanson K, Norton ME, Downum SL, Gonzalez-Velez JM, Sparks TN (2023) Understanding preterm birth in pregnancies complicated by nonimmune hydrops fetalis. Am J Perinatol 40(9):917\u2013922. https:\/\/doi.org\/10.1055\/a-2008-2495","journal-title":"Am J Perinatol"},{"issue":"11","key":"7185_CR9","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/S0022-3468(97)90474-7","volume":"32","author":"JF Bealer","year":"1997","unstructured":"Bealer JF, Mantor PC, Wehling L, Tunell WP, Tuggle DW (1997) Extracorporeal life support for nonimmune hydrops fetalis. J Pediatr Surg 32(11):1645\u20131647. https:\/\/doi.org\/10.1016\/S0022-3468(97)90474-7","journal-title":"J Pediatr Surg"},{"issue":"04","key":"7185_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/PIC-12034","volume":"01","author":"R Witt","year":"2012","unstructured":"Witt R, Raff G, Gundy J, Si M-S (2012) Extracorporeal life support for nonimmune hydrops fetalis. J Pediatr Intensive Care 01(04):207\u2013210. https:\/\/doi.org\/10.3233\/PIC-12034","journal-title":"J Pediatr Intensive Care"},{"issue":"14","key":"7185_CR11","doi-asserted-by":"publisher","first-page":"e698","DOI":"10.1161\/CIR.0000000000000603","volume":"139","author":"KK Stout","year":"2018","unstructured":"Stout KK et al (2018) 2018 AHA\/ACC Guideline for the management of adults with congenital heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation 139(14):e698\u2013e800. https:\/\/doi.org\/10.1161\/CIR.0000000000000603","journal-title":"Circulation"},{"key":"7185_CR12","doi-asserted-by":"publisher","unstructured":"Cuschieri S (2019) The STROBE guidelines. Saudi J Anaesth 13(Suppl 1):S31-S34. https:\/\/doi.org\/10.4103\/sja.SJA_543_18","DOI":"10.4103\/sja.SJA_543_18"},{"issue":"6","key":"7185_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9061789","volume":"9","author":"P Kosinski","year":"2020","unstructured":"Kosinski P, Krajewski P, Wielgos M, Jezela-Stanek A (2020) Nonimmune hydrops fetalis\u2014prenatal diagnosis, genetic investigation, outcomes and literature review. J Clin Med 9(6):1789. https:\/\/doi.org\/10.3390\/jcm9061789","journal-title":"J Clin Med"},{"key":"7185_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jpeds.2017.04.025","volume":"187","author":"MA Steurer","year":"2017","unstructured":"Steurer MA et al (2017) Epidemiology of live born infants with nonimmune hydrops fetalis-insights from a population-based dataset. J Pediatr 187:182-188.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2017.04.025","journal-title":"J Pediatr"},{"issue":"4","key":"7185_CR15","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jpedsurg.2020.09.005","volume":"56","author":"J Cuestas","year":"2021","unstructured":"Cuestas J, Lohmann P, Hagan JL, Vogel AM, Fernandes CJ, Garcia-Prats JA (2021) Mortality trends in neonatal ECMO for pulmonary hypoplasia: a review of the Extracorporeal Life Support Organization database from 1981 to 2016. J Pediatr Surg 56(4):788\u2013794. https:\/\/doi.org\/10.1016\/j.jpedsurg.2020.09.005","journal-title":"J Pediatr Surg"},{"issue":"2","key":"7185_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41372-019-0547-y","volume":"40","author":"J Sharma","year":"2020","unstructured":"Sharma J, Sherman A, Rimal A, Haney B, Weiner J, Pallotto E (2020) Neonatal respiratory extracorporeal membrane oxygenation and primary diagnosis: trends between two decades. J Perinatol 40(2):269\u2013274. https:\/\/doi.org\/10.1038\/s41372-019-0547-y","journal-title":"J Perinatol"},{"issue":"1","key":"7185_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/MAT.0000000000000475","volume":"63","author":"RR Thiagarajan","year":"2016","unstructured":"Thiagarajan RR et al (2016) Extracorporeal Life Support Organization Registry international report 2016. ASAIO Journal 63(1):60. https:\/\/doi.org\/10.1097\/MAT.0000000000000475","journal-title":"ASAIO Journal"},{"issue":"2","key":"7185_CR18","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/MAT.0000000000002128","volume":"70","author":"JE Tonna","year":"2024","unstructured":"Tonna JE et al (2024) Extracorporeal Life Support Organization Registry international report 2022: 100,000 survivors. ASAIO J 70(2):131\u2013143. https:\/\/doi.org\/10.1097\/MAT.0000000000002128","journal-title":"ASAIO J"},{"issue":"12","key":"7185_CR19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1159\/000509243","volume":"47","author":"KT Wild","year":"2020","unstructured":"Wild KT, Hedrick HL, Rintoul NE (2020) Reconsidering ECMO in premature neonates. Fetal Diagn Ther 47(12):927-932. https:\/\/doi.org\/10.1159\/000509243","journal-title":"Fetal Diagn Ther"},{"issue":"3","key":"7185_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1055\/s-0037-1598036","volume":"6","author":"D Bagdure","year":"2017","unstructured":"Bagdure D, Torres N, Walker LK, Waddell J, Bhutta A, Custer JW (2017) Extracorporeal membrane oxygenation for neonates with congenital renal and urological anomalies and pulmonary hypoplasia: a case report and review of the Extracorporeal Life Support Organization Registry. J Pediatr Intensive Care 6(3):188\u2013193. https:\/\/doi.org\/10.1055\/s-0037-1598036","journal-title":"J Pediatr Intensive Care"},{"issue":"11","key":"7185_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2025.162597","volume":"60","author":"SA Vincent","year":"2025","unstructured":"Vincent SA et al (2025) The use of extracorporeal membrane oxygenation in neonates with congenital renal failure. J Pediatr Surg 60(11):162597. https:\/\/doi.org\/10.1016\/j.jpedsurg.2025.162597","journal-title":"J Pediatr Surg"},{"issue":"1","key":"7185_CR22","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1097\/PCC.0b013e3182a553f3","volume":"15","author":"DM McMullan","year":"2014","unstructured":"McMullan DM, Thiagarajan RR, Smith KM, Rycus PT, Brogan TV (2014) Extracorporeal cardiopulmonary resuscitation outcomes in term and premature neonates*. Pediatr Crit Care Med 15(1):e9\u2013e16. https:\/\/doi.org\/10.1097\/PCC.0b013e3182a553f3","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"7185_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.sempedsurg.2023.151335","volume":"32","author":"C Mesas Burgos","year":"2023","unstructured":"Mesas Burgos C, Rintoul N, Broman LM (2023) ECMO for premature neonates- are we there yet?. Semin Pediatr Surg 32(4):151335. https:\/\/doi.org\/10.1016\/j.sempedsurg.2023.151335","journal-title":"Semin Pediatr Surg"},{"issue":"11","key":"7185_CR24","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jpedsurg.2017.03.054","volume":"52","author":"JT Church","year":"2017","unstructured":"Church JT (2017) Pushing the boundaries of ECLS: outcomes in < 34 week EGA neonates. J Pediatr Surg 52(11):1810-1815 https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.03.054","journal-title":"J Pediatr Surg"},{"key":"7185_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21749-5","volume":"12","author":"S Kopfer","year":"2022","unstructured":"Kopfer S et al (2022) Incidence and predictors of brain infarction in neonatal patients on extracorporeal membrane oxygenation: an observational cohort study. Sci Rep 12:17932. https:\/\/doi.org\/10.1038\/s41598-022-21749-5","journal-title":"Sci Rep"},{"issue":"9","key":"7185_CR26","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1007\/s00134-013-2985-x","volume":"39","author":"A Polito","year":"2013","unstructured":"Polito A et al (2013) Neurologic complications in neonates supported with extracorporeal membrane oxygenation. An analysis of ELSO registry data. Intensive Care Med 39(9):1594\u20131601. https:\/\/doi.org\/10.1007\/s00134-013-2985-x","journal-title":"Intensive Care Med"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07185-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07185-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:25:28Z","timestamp":1784283928000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07185-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":26,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["7185"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07185-x","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"21 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local ethics committee of the Medical Center of the University of Bonn (local running number 2026\u2013262-BO). Written informed consent was waived due to the retrospective design of the study. The methods used for the clinical research were performed in accordance with the STROBE (strengthening the reporting of observational studies in epidemiology) guidelines [\n                      \n                      ] and in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was waived due to the retrospective design of the study and the anonymized patient data.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"531"}}